DZ593A1 - Résinate d'un acide carboxylique substitué, procédé pour sa préparation, son utilisation et compositions pharmaceutiques le contenant. - Google Patents

Résinate d'un acide carboxylique substitué, procédé pour sa préparation, son utilisation et compositions pharmaceutiques le contenant.

Info

Publication number
DZ593A1
DZ593A1 DZ847047A DZ847047A DZ593A1 DZ 593 A1 DZ593 A1 DZ 593A1 DZ 847047 A DZ847047 A DZ 847047A DZ 847047 A DZ847047 A DZ 847047A DZ 593 A1 DZ593 A1 DZ 593A1
Authority
DZ
Algeria
Prior art keywords
resinate
preparation
carboxylic acid
pharmaceutical compositions
compositions containing
Prior art date
Application number
DZ847047A
Other languages
English (en)
French (fr)
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Application granted granted Critical
Publication of DZ593A1 publication Critical patent/DZ593A1/fr

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/40Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino groups bound to carbon atoms of at least one six-membered aromatic ring and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08FMACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F8/00Chemical modification by after-treatment
    • C08F8/44Preparation of metal salts or ammonium salts
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/195Carboxylic acids, e.g. valproic acid having an amino group
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/74Synthetic polymeric materials
    • A61K31/785Polymers containing nitrogen
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/58Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin
    • A61K47/585Ion exchange resins, e.g. polystyrene sulfonic acid resin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Polymers & Plastics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DZ847047A 1983-01-12 1984-01-10 Résinate d'un acide carboxylique substitué, procédé pour sa préparation, son utilisation et compositions pharmaceutiques le contenant. DZ593A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH14783A CH655507B (ja) 1983-01-12 1983-01-12

Publications (1)

Publication Number Publication Date
DZ593A1 true DZ593A1 (fr) 2004-09-13

Family

ID=4180317

Family Applications (1)

Application Number Title Priority Date Filing Date
DZ847047A DZ593A1 (fr) 1983-01-12 1984-01-10 Résinate d'un acide carboxylique substitué, procédé pour sa préparation, son utilisation et compositions pharmaceutiques le contenant.

Country Status (41)

Country Link
US (1) US4510128A (ja)
EP (1) EP0122219B1 (ja)
JP (1) JPS59134759A (ja)
KR (1) KR900006747B1 (ja)
AR (1) AR240310A1 (ja)
AT (2) AT391467B (ja)
AU (1) AU570230B2 (ja)
BE (1) BE898649A (ja)
CA (1) CA1218077A (ja)
CH (1) CH655507B (ja)
CS (1) CS269954B2 (ja)
DD (1) DD218373A5 (ja)
DE (2) DE3474152D1 (ja)
DK (1) DK166683B1 (ja)
DZ (1) DZ593A1 (ja)
EG (1) EG16562A (ja)
ES (1) ES8504849A1 (ja)
FI (1) FI82682C (ja)
FR (1) FR2542735B1 (ja)
GB (1) GB2134529B (ja)
GR (1) GR79793B (ja)
HK (1) HK90390A (ja)
HU (1) HU190750B (ja)
IE (1) IE56545B1 (ja)
IL (1) IL70660A (ja)
IT (1) IT1177501B (ja)
LU (1) LU85171A1 (ja)
MA (1) MA20000A1 (ja)
MC (1) MC1564A1 (ja)
MT (1) MTP943B (ja)
NL (1) NL8400098A (ja)
NO (1) NO162862C (ja)
NZ (1) NZ206815A (ja)
OA (1) OA07628A (ja)
PH (1) PH21795A (ja)
PL (1) PL142737B1 (ja)
PT (1) PT77932B (ja)
RO (1) RO88481A (ja)
SE (1) SE457959B (ja)
ZA (1) ZA84212B (ja)
ZW (1) ZW484A1 (ja)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH664085A5 (de) * 1985-02-08 1988-02-15 Ciba Geigy Ag Pharmazeutische praeparate mit analgetischer wirksamkeit, sowie deren herstellung.
ES8604955A1 (es) * 1985-11-08 1986-03-16 Covex Sa Procedimiento para la preparacion de resinatos de la (-) eburnamenina-14-(15h)-ona
US5230885A (en) * 1987-12-23 1993-07-27 Smith Kline & French Laboratories Limited Polystyrene anion exchange polymer pharmaceutical composition
GB8730010D0 (en) * 1987-12-23 1988-02-03 Smith Kline French Lab Compounds
AU608114B2 (en) * 1987-12-23 1991-03-21 Smith Kline & French Laboratories Limited Compounds
CH675537A5 (ja) * 1988-03-25 1990-10-15 Ciba Geigy Ag
SE509029C2 (sv) * 1988-08-16 1998-11-30 Ss Pharmaceutical Co Långtidsverkande diklofenak-natriumpreparat
US4960799A (en) * 1988-09-13 1990-10-02 Ciba-Geigy Corporation Stabilized aqueous solutions of pharmaceutically acceptable salts of ortho-(2,6-dichlorophenyl)-aminophenylacetic acid for opthalmic use
EP0373103B1 (de) * 1988-11-10 1993-03-31 Ciba-Geigy Ag Flüssige orale Formulierung
CA2002492A1 (en) * 1988-11-11 1990-05-11 Sandra T. A. Malkowska Pharmaceutical ion exchange resin composition
GB8911719D0 (en) * 1989-05-22 1989-07-05 Smith Kline French Lab Compounds
GB8913700D0 (en) * 1989-06-14 1989-08-02 Smith Kline French Lab Compounds
GB8913699D0 (en) * 1989-06-14 1989-08-02 Smith Kline French Lab Compounds
US5079001A (en) * 1989-11-03 1992-01-07 Ciba-Geigy Corporation Liquid oral formulation of diclofenac
GB8928278D0 (en) * 1989-12-14 1990-02-21 Smith Kline French Lab Compounds
SE9004129D0 (sv) * 1990-12-21 1990-12-21 Pharmacia Lkb Biotech Anion exchanger
CA2112751A1 (en) * 1991-07-03 1993-01-21 Charles J. Ii Betlach Composition and method for transdermal delivery of diclofenac
DE60232290D1 (de) * 2001-04-09 2009-06-25 Rohm & Haas Kontrollierte Auflösung von Wirkstoffen
US20020176842A1 (en) * 2001-04-09 2002-11-28 Lyn Hughes Extended release of active ingredients
US20030180249A1 (en) * 2002-03-18 2003-09-25 Khanna Satish Chandra Dosage forms for hygroscopic active ingredients
US20050036977A1 (en) * 2003-08-11 2005-02-17 Dilip Gole Taste-masked resinate and preparation thereof
EP1830851A2 (en) * 2004-12-06 2007-09-12 Themis Laboratories Private Limited Rapid disintegrating taste masked compositions and a process for its preparations
DK2018160T3 (da) 2006-03-16 2012-02-06 Tris Pharma Inc Modificeret depotformuleringer indeholdende lægemiddel-ionbytterharpikskomplekser
US7799347B2 (en) * 2006-09-07 2010-09-21 Chondrex Inc. Endotoxin-adsorbent for the prevention and treatment of autoimmune diseases
JP5670336B2 (ja) * 2008-10-02 2015-02-18 ユニヴァーシティ オヴ ピッツバーグ オヴ ザ コモンウェルス システム オヴ ハイアー エデュケーション 全身性炎症の治療のためのポリマー吸着剤の投与
US20120076865A1 (en) 2010-03-24 2012-03-29 Jazz Pharmaceuticals, Inc. Controlled release dosage forms for high dose, water soluble and hygroscopic drug substances
DK2884961T3 (en) 2012-08-15 2019-04-23 Tris Pharma Inc METHYLPHENIDATE TABLE WITH EXTENDED RELEASE
US10398662B1 (en) 2015-02-18 2019-09-03 Jazz Pharma Ireland Limited GHB formulation and method for its manufacture
US11590228B1 (en) 2015-09-08 2023-02-28 Tris Pharma, Inc Extended release amphetamine compositions
US11602513B1 (en) 2016-07-22 2023-03-14 Flamel Ireland Limited Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics
UY37341A (es) 2016-07-22 2017-11-30 Flamel Ireland Ltd Formulaciones de gamma-hidroxibutirato de liberación modificada con farmacocinética mejorada
US11504347B1 (en) 2016-07-22 2022-11-22 Flamel Ireland Limited Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics
US11986451B1 (en) 2016-07-22 2024-05-21 Flamel Ireland Limited Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics
US11602512B1 (en) 2016-07-22 2023-03-14 Flamel Ireland Limited Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics
US20180263936A1 (en) 2017-03-17 2018-09-20 Jazz Pharmaceuticals Ireland Limited Gamma-hydroxybutyrate compositions and their use for the treatment of disorders
US11590081B1 (en) 2017-09-24 2023-02-28 Tris Pharma, Inc Extended release amphetamine tablets
AU2019383389A1 (en) 2018-11-19 2021-05-06 Jazz Pharmaceuticals Ireland Limited Alcohol-resistant drug formulations
CA3127871A1 (en) 2019-03-01 2020-09-10 Flamel Ireland Limited Gamma-hydroxybutyrate compositions having improved pharmacokinetics in the fed state
US11779557B1 (en) 2022-02-07 2023-10-10 Flamel Ireland Limited Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics
US11583510B1 (en) 2022-02-07 2023-02-21 Flamel Ireland Limited Methods of administering gamma hydroxybutyrate formulations after a high-fat meal

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB857193A (en) * 1957-03-14 1960-12-29 Clinical Products Ltd Resin-drug compounds
GB823000A (en) * 1957-10-03 1959-11-04 Clinical Products Ltd Resin-drug compounds
GB869149A (en) * 1958-09-16 1961-05-31 Clinical Products Ltd Liquid pharmaceutical compositions comprising compounds of ion exchange resins and therapeutic substances
US3316282A (en) * 1965-02-08 1967-04-25 Squibb & Sons Inc Anion exchange resin complex of a cycloborate ester of a steroid
NL6817965A (ja) * 1967-12-20 1969-06-24
CH519476A (de) * 1968-03-30 1972-02-29 Hoechst Ag Verfahren zur Herstellung von Salzen von Acylamino-alkylbenzolsulfonyl-harnstoffen mit Anionenaustauschern
US3926864A (en) * 1971-06-21 1975-12-16 Ionics Ion exchange membranes having a macroporous surface area
GB1423694A (en) * 1973-07-10 1976-02-04 Beecham Group Ltd Pharmaceutical compositions
US4058491A (en) * 1975-02-11 1977-11-15 Plastomedical Sciences, Inc. Cationic hydrogels based on heterocyclic N-vinyl monomers
FR2352547A1 (fr) * 1976-05-25 1977-12-23 Viridis Ets Nouvelle resine anionique a action hypocholesterolemiante, son procede de preparation et compositions therapeutiques la contenant
US4217421A (en) * 1977-06-27 1980-08-12 Rohm And Haas Company Anion exchange resins prepared from crosslinked polystyrenesulfonylchloride
US4380590A (en) * 1978-09-19 1983-04-19 Rohm And Haas Company Emulsion copolymer cation exchange resins
IT1106718B (it) * 1978-12-21 1985-11-18 Alfa Farmaceutici Spa Composizioni a base di resine anioniche salificate farmacologicamente attive
US4207399A (en) * 1979-03-14 1980-06-10 Rohm And Haas Company Methylquinoline high polymer based on quaternary ammonium polymers
US4302548A (en) * 1980-05-22 1981-11-24 Rohm And Haas Company Production of ion exchange resins, the resins so produced and ion exchange processes using them

Also Published As

Publication number Publication date
CS17884A2 (en) 1989-10-13
FI840069A0 (fi) 1984-01-09
IE56545B1 (en) 1991-08-28
NL8400098A (nl) 1984-08-01
AU2323084A (en) 1984-07-19
RO88481A (ro) 1986-01-30
AT391467B (de) 1990-10-10
HUT34151A (en) 1985-02-28
DE3400491C2 (ja) 1988-11-10
SE457959B (sv) 1989-02-13
US4510128A (en) 1985-04-09
FI82682B (fi) 1990-12-31
DK166683B1 (da) 1993-06-28
PL142737B1 (en) 1987-11-30
CA1218077A (en) 1987-02-17
MA20000A1 (fr) 1984-10-01
NO162862B (no) 1989-11-20
MTP943B (en) 1984-06-05
LU85171A1 (de) 1984-10-24
SE8400098D0 (sv) 1984-01-10
PT77932A (en) 1984-02-01
MC1564A1 (fr) 1984-11-12
KR900006747B1 (ko) 1990-09-20
GB2134529A (en) 1984-08-15
GR79793B (ja) 1984-10-31
CH655507B (ja) 1986-04-30
AU570230B2 (en) 1988-03-10
AR240310A1 (es) 1990-03-30
IT1177501B (it) 1987-08-26
NZ206815A (en) 1986-08-08
ATE37378T1 (de) 1988-10-15
GB2134529B (en) 1986-09-24
ES528770A0 (es) 1985-05-01
SE8400098L (sv) 1984-07-13
DE3474152D1 (en) 1988-10-27
DD218373A5 (de) 1985-02-06
KR840007562A (ko) 1984-12-08
PH21795A (en) 1988-02-29
PT77932B (en) 1986-07-22
NO840090L (no) 1984-07-13
JPH0257058B2 (ja) 1990-12-03
NO162862C (no) 1990-02-28
DK11884D0 (da) 1984-01-11
ZA84212B (en) 1984-08-29
IT8447527A0 (it) 1984-01-10
HU190750B (en) 1986-10-28
EP0122219B1 (de) 1988-09-21
HK90390A (en) 1990-11-09
JPS59134759A (ja) 1984-08-02
ZW484A1 (en) 1984-08-08
CS269954B2 (en) 1990-05-14
FR2542735B1 (fr) 1986-04-18
BE898649A (fr) 1984-07-11
FI82682C (fi) 1991-04-10
IE840049L (en) 1984-07-12
FI840069A (fi) 1984-07-13
FR2542735A1 (fr) 1984-09-21
IL70660A (en) 1987-08-31
DK11884A (da) 1984-07-13
DE3400491A1 (de) 1984-07-12
OA07628A (fr) 1985-05-23
IL70660A0 (en) 1984-04-30
GB8400251D0 (en) 1984-02-08
EP0122219A3 (en) 1985-05-08
EG16562A (en) 1991-12-30
ATA784A (de) 1990-04-15
EP0122219A2 (de) 1984-10-17
ES8504849A1 (es) 1985-05-01
PL245656A1 (en) 1985-01-02

Similar Documents

Publication Publication Date Title
DZ593A1 (fr) Résinate d'un acide carboxylique substitué, procédé pour sa préparation, son utilisation et compositions pharmaceutiques le contenant.
DZ473A1 (fr) Dérivés de l'acide cis-endo-2-azabicyclo/3,3,o/-octane-3-carboxylique, procédé pour leur préparation, agents contenant ces dérivés et leur utilisation.
FR2555584B1 (fr) Derives de l'acide fluoro-6-dihydro-1,4-oxo-4-piperazinyl substitue-7-quinoline-carboxylique-3 et procede pour leur preparation et compositions pharmaceutiques a action anti-bacteriennes a base desdits derives
BE890574A (fr) Derive d'aminoalcoyl-furanne, procede pour sa preparation et composition pharmaceutique le contenant
FR2569402B1 (fr) Derives d'acide 3,5-pyridine-dicarboxylique, procede pour leur preparation et composition pharmaceutique les contenant
MC1915A1 (fr) Procédés pour la préparation de 2',3'-didésoxynucléosides et de formulations pharmaceutiques en contenant
FR2501204B1 (fr) Derives d'un acide quinoleine-carboxylique, procede pour les preparer et medicament en contenant
LU81132A1 (fr) 2-(2-thenoylthio)-propionylglycine,procede pour sa preparation et compositions pharmaceutiques la contenant
FR2499408B1 (fr) Composition pharmaceutique pour le traitement de l'osteopathie, a base d'acide 6-amino-1-hydroxyhexane-1,1-diphosphonique
BE880155A (fr) Complexes d'inclusion de cyclodextrine-camomille, procede pour leur preparation et compositions contenant de tels complexes
FR2569702B1 (fr) Nouvelle 4'-deschlororebeccamycine, composition pharmaceutique la contenant et procede pour sa preparation
FR2517670B1 (fr) Sel d'acide (+)-2-(2-fluoro-4-biphenylyl)propionique, procede pour sa preparation et composition pharmaceutique le contenant
ZA828085B (en) Derivatives of cis,endo-2-azabicyclo-(3.3.0)-octane-3-carboxylic acid,a process for their preparation,agents containing these compounds and their use
FR2555595B1 (fr) Procede pour la preparation d'une composition contenant un anhydride alcenyl succinique
DE3160595D1 (en) Polyprenyl carboxylic acid derivatives, process for the preparation of the same, and pharmaceutical compositions
FR2507605B1 (fr) Procede de preparation d'esters d'acides apovincaminiques, esters ainsi obtenus et compositions pharmaceutiques preparees avec ces esters
PT68306A (fr) Procede pour la preparation d'une composition pharmaceutique contenant des nouvaux composes organiques
PT88634A (pt) A process for the preparation of catechol carboxylic acid derivatives and of pharmaceutical compositions containing the same
IT7925802A0 (it) Composti dell'acido idrossamico; metodo per la loro preparazione; e medicamenti contenenti i detti composti.
PT65264A (fr) Procede pour la preparation d'une composition pharmaceutique contenant des composes organiques
PT78776A (fr) Procede de preparation de derives de l'acide bicyclo(3.2.1.)carboxylique et de compositions pharmaceutiques les contenant
FR2585953B1 (fr) Composition pharmaceutique pour l'administration orale contenant de l'ubiquinone et procede
FR2529550B1 (fr) Derives d'acide apovincaminique, procede pour leur preparation et compositions pharmaceutiques contenant ces derives
FR2515961B1 (fr) Preparations medicamenteuses contenant un derive d'acide tetraiodothyrocarboxylique notamment pour le traitement de l'hypercholesterolemie
IL63683A (en) N-(2-(carboxamino)acetyl))dihydroindole or tetrahydroisoquinoline carboxylic acid derivatives,process for their preparation and pharmaceutical compositions containing same